Stability of clonally related DNA fingerprints and cell-wall peptide patterns in geographic isolates of multiresistant epidemic clones of Streptococcus pneumoniae  by Nesin, Mirjana et al.
Original Report 
Stability of Clonally Related DNA Fingerprints and Cell-Wall 
Peptide Patterns in Geographic Isolates of Multiresistant 
Epidemic Clones of Streptococcus pneumolziae 
Mirjana Nesin, MD;*+ Anatoly Severin, PhD;* and AlexanderTomasz, PhD* 
ABSTRACT 
Objective: To determine the stability of multidrug-resistant epi- 
demic clones of Streptococcus pneumoniae. 
Methods: Polymerase chain reaction (PCR) was used to amplify 
the penicillin-binding protein (PBP) genes IA, 2X, and 2B, fol- 
lowed by fingerprinting after restriction digestion of the ampli- 
fied molecules. Cell walls were isolated, digested by the autolytic 
amidase of pneumococcus, and the family of stem peptides 
was separated by high-pressure liquid chromatography. 
Results: Twenty-eight isolates of multidrug-resistant capsular 
type 6B S. pneumoniae recovered in Iceland between 1990 
and 1992 and ten isolates of the multidrug-resistant capsular 
type 23F S. pneumoniae recovered in the United States, Por- 
tugal, Croatia, and South Korea between 1989 and 1996 were 
compared for restriction fragmentation length polymorphism 
(RFLP) of their PBP genes IA, 2X, and 2B, using the PCR for 
amplification. Five isolates each of the multidrug-resistant cap- 
sular type 6B pneumococci from Iceland and the capsular type 
23F isolates from Cleveland, Ohio, were also compared for 
their muropeptide profiles, using a high-performance liquid 
chromatography (HPLC) system to separate the family of stem 
peptides generated by enzymatic hydrolysis. The isolates rep- 
resenting the two major and internationally spread epidemic 
clones have retained the clone-specific RFLP fingerprints of 
their PBP genes and also reproduced distinct cell-wall stem 
peptide patterns characteristic of the two pneumococcal 
clones. 
Conclusions: The data further document the considerable sta- 
bility of clonal types of the multiresistant epidemic clones of S. 
pneumoniae over time and over a wide range of geographic iso- 
lation sites. 
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Of the very large number of penicillin-resistant clones of 
Streptococcus pneumoniae, only a few have been shown 
to spread extensively over large geographic distances. 
One of these, a multidrug-resistant clone sometimes 
referred to as the Spanish/USA clone usually expressing 
a capsular type 23F,’ was documented to have spread 
extensively in Europe,lm9 the United States,1,10-12 South 
Africa,13J* South Korea,15J6 and South America.” Another 
distinct multidrug-resistant lineage, referred to as the 
Spanish/Icelandic clone and expressing capsular type GB, 
was spread extensively in Spain, the United Kingdom, 
and Iceland,ls where these bacteria have reached a sur- 
prisingly high prevalence and have been shown to be 
responsible for up to 20% of all invasive pneumococcal 
disease between 1993 and 1996.19 
The microbial factors that may be involved with the 
epidemicity of these two clones are not known at the pre- 
sent time.To understand the factors that contribute to the 
extensive geographic spread of these clones, it was impor- 
tant to test the stability of the clone-specific properties of 
these bacteria. Earlier studies have already established the 
uniformity of the multidrug-resistant Icelandic isolates with 
regard to their multilocus enzyme profiles and pulsed-field 
gel electrophoretic (PFGE) profiles.‘* Evidence was also 
obtained for the similarity of PFGE patterns in isolates 
belonging to the Spanish/USA clone from South Korea,‘j 
Croatia,* PortugaJ6 France,2 and the United States.‘O Recent 
work also has established that isolates of this capsular type 
23F clone recovered in South Africa and Germany share 
PBP mosaic genes of comparable fingerprint patterns.3s16 
The ultimate purpose of this line of investigations is to 
obtain some insight into microbial factors involved with 
the remarkable epidemicity of these pneumococcal clones. 
In the investigations described here, the characterization 
of pneumococcal isolates belonging to the Spanish/USA 
and Spanish/Icelandic clones were extended by deter- 
mining their PBP fingerprint patterns and by comparing 
the stem peptide composition of their peptidoglycans. 
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MATERIAL AND METHODS 
Bacterial Strains 
Twenty-eight serotype 6B isolates were selected from the 
Icelandic strains, previously characterized by Soares et 
a1.18 Most of these isolates already had been shown to 
share an identical and unique pulsed-field gel elec- 
trophoresis (PFGE) pattern and multilocus enzyme pro- 
file, and they exhibited identical patterns of multidrug 
resistance to six antibacterial agents.lx Ten serotype 23F 
multiresistant isolates from different geographic locations 
(two each from New York City, North Carolina, Croatia, 
Portugal, and South Korea) and four penicillin-susceptible 
isolates of the same serotype from North Carolina, were 
from the S.pneumoniae strain collection at Rockefeller 
UniversityThe penicillin-resistant 23F isolates shared sim- 
ilar PFGE patterns and multilocus enzyme profiles.’ Some 
relevant properties of these isolates are summarized in 
Table 1. Antibiotic susceptibilities were determined by 
disk diffusion following recommendations and breakpoint 
definitions of the National Committee for Clinical Labo- 
ratory Standards (NCCLS).20 
Source 
Table 1. Some Relevant Properties of the Multiresistant Streptococcus pneumoniae Strains 
Antibiotic Resistance 
PFGE 
Gene Profile 
Strain Serotype Pen M/C Cam Tel Ery Pattern PBP 1A PBP 2x PBP 28 
Iceland Ic 23 
Ic 27 
Ic 28 
Ic 30 
Ic 33 
Ic 34 
Ic 35 
Ic 36 
Ic 39 
Ic 40 
Ic 41 
Ic 42 
Ic 43 
Ic 44 
Ic 45 
Ic 46 
lc 48 
Ic 49 
Ic 50 
Ic 51 
Ic 52 
Ic 53 
Ic 54 
Ic 55 
Ic 56 
Ic 57 
Ic 58 
Ic 60 
Spain Md 1238 
Sp 647 
S&652 
Alaska Ala1 
Ala31 
New York City Alb 
North Carolina 230 
231 
Portugal 1013 
1118 
Croatia 28 
35 
South Korea 2 
4 
North Carolina 30 
119 
157 
6B 2 
6B 1 
6B 1 
6B I 
6B 1 
6B 2 
6B 1 
6B 1 
6B 1 
6B 1 
6B 2 
6B 1 
6B 1 
6B 1 
6B 1 
6B 1 
6B 0.5 
6B 0.5 
6B 0.5 
6B 1 
6B 0.5 
6B 0.5 
6B 0.5 
6B 0.5 
6B 1 
6B 2 
6B 2 
6B 0.5 
6B 2 
6B 2 
6B 2 
6B 0.1 
6B 0.1 
23F R 
23F R 
23F R 
23F R 
23F R 
23F R 
23F R 
23F R 
23F R 
23F S 
23F S 
23F S 
R 
I 
R 
R 
I 
R 
I 
I 
I 
I 
I 
I 
R 
R 
R 
R 
R 
R 
S 
R 
R 
I 
I 
R 
I 
R 
R 
- 
- 
S 
S 
R 
R 
R 
R 
R 
R 
R 
R 
R 
S 
S 
S 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
S 
S 
R 
R 
R 
R 
R 
R 
R 
R 
R 
S 
S 
S 
R 
I 
R 
R 
R 
R 
I 
R 
R 
R 
I 
R 
R 
R 
S 
R 
R 
R 
R 
I 
R 
R 
R 
R 
R 
R 
R 
R 
R 
- 
- 
S 
I 
S 
R 
R 
S 
S 
S 
S 
R 
R 
S 
S 
S 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
- 
- 
- 
1 
1 
I 
1 
1 
1 
1 
1 
1 
1 
1 
2 
2 
2 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
I 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 I+2 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 1 
1 I+3 
1 I+3 
2 4 
1 4 
3 5 
3 5 
3 5 
3 5 
3 5 
3 5 
3 5 
3 5 
3 5 
4 6 
4 6 
4+5 6 
*Minor variants of PFGE types OL and 4. 
PFGE = pulsed-field gel electrophoresis; Pen = penicillin: Cam = chloramphenicol; Tet = tetracycline; Ery = etythromycin. Susceptibilites defined according to 
NCCLS.20 
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Isolation of the Penicillin-Binding 
Protein Genes lA, 2B, and 2X 
The fragments of genes coding for the penicillin-binding 
domains of PBPs lA, 2B, and 2X were amplified from the 
chromosomal DNA by PCR.The protocol used was a mod- 
ification of the method described by Zhang et al.‘l Pneu- 
moccocal isolates were grown in a casein-hydrolysate- 
based and yeast extract supplemented (C + Y) medium 
until ODGOO = 0.7 to 0.9 was reached.22 Three micro- 
liters of the cultures were diluted in 147 microliters of 
water and lysed by immersing in a boiling water bath for 
2 minutes. Cell lysates were used directly for the PCR.The 
gene fragments of PBP 2X and 2B were each amplified 
in a 50 FL reaction mixture containing 35 ~.LL of cell 
lysate, 2 mM MgCl,, 1 PM oligonucleotide primers, 0.2 
mM deoxynucleoside triphosphates, 1.25 ~J,L of Taq DNA 
polymerase, and 5 yL of 10X PCR buffer (Gene Amp PCR 
Core Reagents, Perkin Elmer, Branchville, NJ). The gene 
fragments of PBP 1A were amplified in the 100 FL reac- 
tion mixture. The composition of the reaction mixture 
was the same as that used for the amplification of PBP 
2X and PBP 2B gene fragments.The 1.5-kb PBP 2B gene 
fragments were amplified using the primers Pn 28 up 
and J+z 28 down as described by Dowson et a1.23 The 
2-kb PBP 2X gene fragments were amplified using primers 
Pn 2X up and Pn 2X down as described by Munoz et 
al.‘* The gene coding PBP 1A was amplified as a 2.2-kb 
fragment with the oligonucleotides Pn la and Pn la rev, 
as described by McDougal et aLz5 The PCR cycling con- 
ditions were: denaturation at 95°C for 5 minutes and 72°C 
for 10 minutes; 30 cycles of 90°C for 30 seconds, 50°C 
for 30 seconds, and 72°C for 3 minutes, and a final exten- 
sion period of 72°C for 7 minutes. Amplified fragments 
were purified by preparative electrophoresis from the 
5% polyacrylamide gel as described by Maxam and 
Gilbert.z6 
DNA Fingerprinting of Penicillin-Binding 
Protein Genes lA, 2B, and 2X 
The original method described by Zhang et al was used 
according to the modifications introduced by Munoz et 
a1.21,24 The amplified fragments of PBP lA, 2X, and 2B 
genes were digested with Hi@ and StyLThe PBP 2X frag- 
ments also were digested with MseI and DdeI. Of these 
restriction nucleases, Hinfl and Sty1 proved to have the 
best resolving power, and therefore, only fingerprints 
obtained with these enzymes are shown in the figures. 
Restriction fragments were end-labelled: [35S]dCTP was 
used for Sty1 generated fragments and [35SldATP for Hinfl, 
or MseI and DdeI generated fragments. Fragments were 
separated on an 8% nondenaturing polyacrylamide gel 
(25 X 20cm)The samples were electrophoresed at 150 V, 
until a bromphenol blue marker dye reached 5 mm from 
the bottom of the gel, transferred to filter paper, dried 
under vacuum, and autoradiographed. 
Plasmid DNA pBR322 digested with MspI and 
labelled with [35S]dCTP was used as a size marker. Frag- 
ment sizes are: 622,527,404,307,242, -200, -180, -160, 
-150,120,110,90,76,67, and 34 base pairs from the bot- 
tom to the top, respectively. 
Cell-Wall Stem Peptide Fingerprints 
Procedures for the isolation and enzymatic digestion of 
cell walls and the separation of the family of stem pep- 
tides by reverse phase high-performance liquid chro- 
matography (HPLC) have been described.27,28 
RESULTS 
The pneumococcal isolates examined here have already 
been examined by PFGE and multilocus enzyme analysis 
(MLEA).The apparent stability of the multiresistant Span- 
ish/USA and Spanish/Icelandic clones over large geo- 
graphic distances and considerable time intervals 
between dates of isolation is surprising in view of the 
capacity of S. pneumoniae to undergo spontaneous 
genetic transformations in vivo. Indeed, determinants 
encoding the capacity of pneumococci to develop com- 
petence for genetic transformation were recently shown 
to be ubiquitous among natural isolates of this bacterial 
species.29 The stability of these two widely spread mul- 
tiresistant clones may be related to the presence of some 
microbial factors involved with the superior epidemic&y 
of the two clones. In an attempt to obtain some further 
insight into this question, we undertook to examine the 
clone-specific fingerprints of the PBP genes in represen- 
tatives of the 23F and 6B pneumococcal clones, and also 
examine the composition of their cell-wall peptidogly- 
can. Uniformity of PFGE and MLEA patterns in these iso- 
lates does not exclude the possibility of modification or 
replacement of the original clone-specific PBP genes 
among these isolates. In vivo acquisition and exchange of 
resistant PBP genes and genes involved with the synthe- 
sis of the polysaccharide capsule without effect on the 
chromosomal macrorestriction pattern have been docu- 
mented.30,31 Determination of the composition of the pep 
tidoglycan was of particular interest, since the radically 
altered cell-wall composition in some penicillin-resistant 
pneumococci has raised the possibility that such modi- 
fication of cell-wall composition may be a frequent or 
even obligatory consequence of the alteration of peni- 
cillin-binding proteins in resistant pneumococci. 
DNA Fingerprints of Icelandic Isolates 
Twenty-eight isolates of serotype 6B multidrug-resistant 
S. pneumoniae causing clinical infections in Iceland 
between April 1989 and September 1991 were analyzed 
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Figure 1. DNA fingerprint patterns of the PBP genes 1 A, 2X, and 28 
amplified from multidrug-resistant capsular type 6B isolates from Ice- 
land. A, (HirVl) and B, (Styl) DNA fingerprints of PBP 1A from a group 
of Icelandic isolates identified through strain numbers marking the lanes 
in the gels. C, PBP 2X fingerprints generated by Hinfl digestion; D, 
(Styl) and E (H&l) PBP 28 fingerprints of a select group of Icelandic 
isolates. Other properties of these strains are presented in Table 1. 
(see Table 1). An earlier study had already established the 
similarity of genetic backgrounds in these strains, using 
PFGE of SmaI macrorestriction digests and MLEA.” In 
the present study, characterization was extended to the 
comparison of the PBP mosaic gene fingerprints of these 
isolates. Figure 1 illustrates the PBP 1A DNA fingerprints 
obtained by the use of Hin. (Figure 1, A) and Sty1 
PBP 28 (Hinf) 
Iceland Ala Sp -- 
h 54 55 56 57 58 ,60 1 31 647 
Figure 2. DNA fingerprints of the PBP 2B gene amplified from cap- 
sular type 6B penicillin-resistant isolates originating in Iceland, Alaska, 
and Spain. Other proper-ties of these strains are shown in Table 1. 
(Figure 1, B) enzymes, and fingerprints for PBP 2X are 
shown in Figure 1, C. The similarity of fingerprint pat- 
terns is apparent. 
Figure 3. DNA fingerprints of PBP genes IA and 2X amplified from multidrug-resistant capsular type 23F S. pneumoniae recovered at a vari- 
ety of geographic locations, Penicillin-binding protein genes are amplified using the restriction enzyme Hinfl for PBP IA (A) and for PBP 2X (B). 
The origin of these strains is indicated. 
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Figure 4. DNA fingerprints of the PBP 28 gene amplified from multi- 
drug-resistant capsular type 23F S. pneumoniae recovered at different 
geographic locations. The PBP 2B fingerprints were generated by the 
Hinfl restriction endonuclease. 
The DNA fingerprints of the PBP 2B gene for a select 
group of Icelandic isolates is shown in Figure 1, D. Again, 
similarity of fingerprints is apparent with the exception 
of a single isolate, Ic 45, in which one of the two restric- 
tion nucleases (Hi@) was able to detect a differential 
fingerprint pattern. Interestingly, Ic 45 previously had 
been shown to be distinguishable from the other Ice- 
landic isolates through a small change in PFGE pattern 
and through change in one of the alleles used in the 
MLEA.18 Icelandic isolate 45, unlike most of the other 
Icelandic strains, was found to be susceptible to 
erythromycin. 
Figure 2 shows Hi@ fmgerprints of the PBP 2B gene 
from a group of additional serotype 6B isolates from Ice- 
land and also from a Spanish and from two Alaskan iso- 
lates. The Spanish isolate, Sp 647, and the two Alaskan 
isolates, Ala1 and Ala 31, each belonged to two distinct 
I I I 
25 
I 
50 
I I I 
75 25 50 75 
Time (min) 
Figure 5. High-performance liquid chromatography elution profiles 
of stem peptides generated by enzymatic hydrolysis of cell walls of 
four S. pneumoniae strains: strain R36A, a penicillin-susceptible labo- 
ratory strain showing the species-specific stem peptide profile of S. 
pneumoniae; strain Pen 6, a penicillin-resistant transformant derivative 
of a South African multiresistant strain of fneumococcus; Ic 24 is rep- 
resentative of the capsular type 6B Spanish/Icelandic clone, and Ohio 
7, of the capsular type 23F Spanish/USA clone. Roman and Arabic 
numerals refer to different stem peptide species, the structures of which 
are shown in Figure 6. 
genetic lineages characterized through PFGE and MLFA.** 
Figure 2 shows that the PBP 2B fmgerprints of these three 
distinct penicillin-resistant clones also reflected their dif- 
ferences: common fingerprints were shared by the Ice- 
landic isolates; a distinct fingerprint was produced by 
Sp 647 and a third, different, fingerprint is shown by the 
two Alaskan strains. 
DNA Fingerprints of Multiresistant Capsular 
‘Qpe 23F Isolates of S. pneumoniae 
Recovered at Distant Geographic Locations 
Ten clonally related serotype 23F isolates were analyzed: 
two each from NewYork City, North Carolina,iz Portugal6 
Croatia,* and South Korea.15 These isolates were consid- 
ered to be clonally related since they have shown the same 
antibiotic susceptibilities and the same PFGE patterns.The 
DNA fingerprint patterns generated by Hi@ of the PBP 1A 
and 2X genes (Figure 3) and those of the PBP 2B genes 
(Figure 4) were identicalThe use of restriction nuclease 
Sty1 confirmed the identity of these patterns. 
Whereas the DNA fingerprints of the PBP genes 2X 
and 28 were each unique for the two particular multire- 
sistant clones, the PBP 1A fingerprints of the Icelandic and 
Spanish/USA clonal isolates were similar and did not allow 
distinction between these two lineages.This finding con- 
firmed the observation already noted by Martin et a1,32 
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R36A 
1 2 3 
Ala Ala Ala 
I I I 
iGln iGln iGln 
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iGln iGln 
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A\a Ala 
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I I I 
iGln iGln iGln 
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I I 
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&YS  JYS 
/jla,NaaN Aia,flaMva 
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I I I 
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IX 
Ala Ala Ala 
I I I 
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Figure 6. Structures of stem peptides identified in strains R36A and Pen 6 of S. pneumoniae. 
Identification of the structure of these stem peptides was done in previous studies.Z7,*8 
who showed that the DNA fiigerprints of PBP IA may 
not be useful markers for molecular epidemiology. 
Three penicillin-susceptible 23F serotype isolates 
also were compared for their corresponding PBP fin- 
gerprints.These isolates shared among themselves com- 
mon patterns that were different from those of either the 
capsular type 6B or the 23F multiresistant isolates (see 
Table 1). 
Cell-Wall Stem Peptide Patterns in Representative 
Isolates of the Spanish/Icelandic and the Spanish/ 
USA Clones of Streptococcus pneumoniae 
Penicillin-resistant clinical isolates of S. pneumoniae 
often show an abnormal stem peptide composition in 
their peptidoglycans, which deviate from the common 
and species-specific peptidoglycan pattern common to 
penicillin-susceptible strains.z7 Cell walls were isolated 
from five capsular type 6B Icelandic isolates (Ic 24, 25, 
26,3 1, and 32) and five capsular type 23F isolates (Ohio 
3-7) and the muropeptide patterns were determined 
after digestion with pneumococcal autolytic amidase fol- 
lowed by separation on reverse-phase HPLC columns. 
Figure 5 shows the stem peptide profiles of one of the 
Icelandic isolates (Ic 24) and one of the Spanish/USA 
isolates (Ohio 7). Also shown for comparison are the 
stem peptide patterns of strain R36A (the prototype of 
the species-specific stem peptide composition) and the 
grossly distorted stem peptide composition shown by 
strain Pen 6, which is a genetic transformant constructed 
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Table 2. Cell-Wall Stem Peptide Composition of Penicillin-Resistant Pneumococcal Isolates belonging to the Icelandic Serotype 6B Clone 
C/one 
Iceland 
Serotype 
66 
Ic 24 
Ic 25 
Ic 26 
Ic 31 
Ic 32 
Mean 
R36A 
Pep tide Material (%) 
Dimer Total Peptide (%) 
Recovery Monomer and Linear Branched 
1 2 3 I II 4 111 5 6 7 IV v 8 VI 9 W) (%) Trimer (%) (L) (B) 
26.8 2.8 4.0 4.3 0.5 26.2 0.1 11.8 13.0 0.9 0.8 1.0 3.5 3.0 1.3 74 38 62 67 33 
28.3 3.0 6.0 3.0 0.4 25.7 0.1 14.6 9.0 2.3 0.7 0.8 3.4 1.4 1.3 75 41 59 6% 32 
27.5 2.0 4.8 3.1 0.5 29.8 0.2 11.7 9.9 1.8 0.3 0.8 3.7 3.1 0.8 76 38 62 69 31 
28.9 1.2 6.0 3.6 0.4 27.1 0.2 12.8 9.5 2.1 0.6 0.6 3.6 1.8 1.7 74 40 60 68 32 
29.9 1.2 4.1 3.6 0.4 31.0 0.2 9.2 9.4 2.4 0.6 0.8 3.5 2.3 1.3 76 39 61 71 29 
28.3 2.0 5.0 3.5 0.4 28.0 0.2 12.0 10.2 1.9 0.6 0.8 3.5 2.3 1.9 39 61 69 31 
22.3 4.5 3.7 1.5 - 31.2 2.2 14.4 5.7 4.5 0.7 0.7 5.7 - 2.2 34 66 70 30 
B:L 
0.5 
0.5 
0.45 
0.5 
0.4 
0.5 
0.4 
by crossing DNA from the highly penicillin-resistant 
South African strain into strain R36A, and selecting for 
donor level penicillin resistance.33 The numbers assigned 
to the peptide peaks represent differently structured 
stem peptides, the chemical formulae of which are 
shown in Figure 6. 
The quantitative composition of the peptidoglycans 
resolved to 15 different stem peptides is shown inTable 
2, for the five Icelandic isolates, and inTable 3, for the five 
Spanish/USA serotype 23F isolates. Comparison of the 
means of representation of the different stem peptide 
species in the two different multiresistant clones to those 
of strain R36A shows that these particular multiresistant 
clones had similar composition to that of the species-spe- 
cific peptidoglycan of S.pneumoniae.**The main differ- 
ences were in the ratio of the major monomeric (peptide 
1) and dimeric (peptide 4) components: whereas in the 
species-specific pattern (R36A) there was an abundance 
of peptide 4 (31.2%) over peptide 1 (22.3%) the ratio of 
these two peptides was close to unity in the Icelandic iso- 
lates (28% each) and the monomeric peptide 1 (24.8%) 
was more abundant than peptide 4 (19.6%) in members 
of the multiresistant serotype 23F clone (see Table 3). 
Additional, significant changes were apparent in some of 
the less abundant peptide components (for instance, the 
reduced amounts in peptide III in the Icelandic isolates 
or the increase of peptide VI in both the Icelandic and 
the 23F isolates over the representation of these stem 
peptides in the peptidoglycan of strain R36A (see Tables 
2 and 3). 
SUMMARY 
The DNA fingerprinting and cell-wall profiling data 
described here confirm the stability of the Icelandic and 
Spanish/USA clones over different isolation dates and dif- 
ferences in geographic sites of isolationThe continued 
worldwide spread of these multiresistant clones makes it 
important to better understand microbial factors that may 
be associated with the epidemicity of these pneumo- 
coccal genetic lineages. It is conceivable that the relative 
closeness of the cell-wall composition of these two clones 
to that of the species-specific composition of cell wall 
conserved among antibiotic susceptible S. pneumoniae 
isolates contributes to the “fitness” and the stability of 
these multiresistant lineages, as evidenced by their abil- 
ity for massive geographic expansion. 
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